세계의 뇌졸중 후처리 소프트웨어 시장 예측(-2030년)

Market Overview

The Stroke Post Processing Software Market is expected to register a CAGR of 8.64% during the review period.

The stroke post processing software market is ready for significant development driven by expanding stroke rates, high level imaging innovations, developing accentuation on convenient and precise analysis. As medical services suppliers focus on productive examination of clinical pictures for worked on quiet results, the market is supposed to observe persistent extension, offering refined arrangements in the field of neuroimaging.

The development of the stroke post processing software market is credited to the rising predominance of strokes, developing mindfulness among patients, and rising number of key drives.

As the quantity of strokes rises, so will the interest for stroke the board frameworks and software. Also, as per the Places for Infectious prevention and Counteraction (CDC), stroke is supposed to represent one in each six passings in the US by 2020. The utilization of stroke post-processing software empowers the improvement of additional effective pathways, quicker treatment choices, and better quiet results.

In this way, the rising number of patients with stroke is adding to the development in the worldwide market. Furthermore, a few factors like segment changes, natural circumstances, and expanding mental pressure are additionally bringing about rising stroke cases, in this manner filling the market development during the forecast time frame.

Market Segment Insights

The Stroke Post Processing Software Market segmentation, based on installation, includes desktops and mobile phone & tablets. The Stroke Post Processing Software Market segmentation, based on modality, includes MRI and CT scan.

The Stroke Post Processing Software Market segmentation, based on type, includes ischemic stroke, hemorrhagic stroke, and others. The Stroke Post Processing Software Market segmentation, based on end user, includes hospital & clinics, specialty centers, and others.

Regional Insights

The North America stroke post processing software media market represented the biggest market share in 2022. Key variables ascribed to its enormous offer incorporate created medical services foundation, expanding mechanical headway, and the presence of many market players in the region.

Europe stroke post processing software market represented the second-biggest market share because of developing predominance of ischemic stroke among people, and the rising familiarity with treatment. Moreover, the Germany stroke post processing software market is ascribed to hold the biggest market share, and the France stroke post processing software market is extended be the quickest developing market in the Europe region.

The Asia-Pacific stroke post processing software market is supposed to be the quickest developing from 2023 to 2030 because of developing headway in imaging advancements, expanding assets in research exercises, and rising commonness of strokes. Also, China stroke post processing software market accounted to hold the biggest market share, and the India stroke post processing software market is projected to be the rapid developing market in the Asia-Pacific region.

Major Players

Key Companies in the Stroke Post Processing Software market are Canon Medical Informatics, GE Healthcare (US), Siemens Healthineers (Germany), ai, Inc (US), Koninklijke Philips N.V. (Netherlands), Inc (US), TeraRecon Inc (US), Brainomix (UK), Icometrix (Belgium), Nicolab B.V. (Netherlands), and RapidAI (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY INSTALLATION

• 4.1 OVERVIEW
• 4.2 DESKTOPS
• 4.3 MOBILE PHONE & TABLETS

5 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY MODALITY

• 5.1 OVERVIEW
• 5.2 MRI
• 5.3 CT SCAN

6 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 ISCHEMIC STROKE
• 6.3 HEMORRHAGIC STROKE
• 6.4 OTHERS

7 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY END USER

• 7.1 OVERVIEW
• 7.2 HOSPITAL& CLINICS
• 7.3 SPECIALTY CENTERS
• 7.4 OTHERS

8 GLOBAL STROKE POST PROCESSING SOFTWARE MARKET, BY REGION

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 US
  • 8.2.2 CANADA
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 FRANCE
  • 8.3.3 UK
  • 8.3.4 ITALY
  • 8.3.5 SPAIN
  • 8.3.6 REST OF EUROPE
• 8.4 ASIA-PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 INDIA
  • 8.4.3 JAPAN
  • 8.4.4 SOUTH KOREA
  • 8.4.5 AUSTRALIA
  • 8.4.6 REST OF ASIA-PACIFIC
• 8.5 REST OF THE WORLD
  • 8.5.1 AFRICA
  • 8.5.2 LATIN AMERICA
  • 8.5.3 MIDDLE EAST

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPETITIVE BENCHMARKING
• 9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL STROKE POST PROCESSING SOFTWARE MARKET
• 9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL STROKE POST PROCESSING SOFTWARE MARKET
• 9.5 KEY DEVELOPMENT ANALYSIS
• 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 9.6.1 PRODUCT/SERVICE APPROVAL AND PRODUCT LAUNCH
  • 9.6.2 PARTNERSHIP/AGREEMENT/INVESTMENT/CONTRACT/EXPANSION/ INVESTMENT
• 9.7 MAJOR PLAYERS FINANCIALS
  • 9.7.1 SALES (USD MILLION), 2022
  • 9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

10 COMPANY PROFILES

• 10.1 GE HEALTHCARE
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 FINANCIAL OVERVIEW
  • 10.1.3 PRODUCTS OFFERED
  • 10.1.4 KEY DEVELOPMENTS
  • 10.1.5 SWOT ANALYSIS
  • 10.1.6 KEY STRATEGIES
• 10.2 SIEMENS HEALTHINEERS
  • 10.2.1 COMPANY OVERVIEW
  • 10.2.2 FINANCIAL OVERVIEW
  • 10.2.3 PRODUCTS OFFERED
  • 10.2.4 KEY DEVELOPMENTS
  • 10.2.5 SWOT ANALYSIS
  • 10.2.6 KEY STRATEGIES
• 10.3 VIZ.AI, INC.
  • 10.3.1 COMPANY OVERVIEW
  • 10.3.2 FINANCIAL OVERVIEW
  • 10.3.3 PRODUCTS OFFERED
  • 10.3.4 KEY DEVELOPMENTS
  • 10.3.5 KEY STRATEGIES
• 10.4 NICOLAB B.V.
  • 10.4.1 COMPANY OVERVIEW
  • 10.4.2 FINANCIAL OVERVIEW
  • 10.4.3 PRODUCTS OFFERED
  • 10.4.4 KEY DEVELOPMENTS
  • 10.4.5 KEY STRATEGIES
• 10.5 TERARECON, INC
  • 10.5.1 COMPANY OVERVIEW
  • 10.5.2 FINANCIAL OVERVIEW
  • 10.5.3 PRODUCTS OFFERED
  • 10.5.4 SWOT ANALYSIS
  • 10.5.5 KEY DEVELOPMENTS
  • 10.5.6 KEY STRATEGIES
• 10.6 BRAINOMIX
  • 10.6.1 COMPANY OVERVIEW
  • 10.6.2 FINANCIAL OVERVIEW
  • 10.6.3 SERVICES OFFERED
  • 10.6.4 KEY DEVELOPMENTS
  • 10.6.5 SWOT ANALYSIS
  • 10.6.6 KEY STRATEGIES
• 10.7 CANON MEDICAL INFORMATICS, INC.
  • 10.7.1 COMPANY OVERVIEW
  • 10.7.2 FINANCIAL OVERVIEW
  • 10.7.3 SERVICES OFFERED
  • 10.7.4 KEY DEVELOPMENTS
  • 10.7.5 KEY STRATEGIES
• 10.8 KONINKLIJKE PHILIPS N.V.
  • 10.8.1 COMPANY OVERVIEW
  • 10.8.2 FINANCIAL OVERVIEW
  • 10.8.3 PRODUCTS OFFERED
  • 10.8.4 KEY DEVELOPMENTS
  • 10.8.5 SWOT ANALYSIS
  • 10.8.6 KEY STRATEGIES
• 10.9 ICOMETRIX
  • 10.9.1 COMPANY OVERVIEW
  • 10.9.2 FINANCIAL OVERVIEW
  • 10.9.3 PRODUCTS OFFERED
  • 10.9.4 KEY DEVELOPMENTS
  • 10.9.5 KEY STRATEGIES
• 10.10 RAPIDAI
  • 10.10.1 COMPANY OVERVIEWS
  • 10.10.2 FINANCIAL OVERVIEW
  • 10.10.3 PRODUCTS OFFERED
  • 10.10.4 KEY DEVELOPMENTS
  • 10.10.5 KEY STRATEGIES

11 APPENDIX

• 11.1 REFERENCES
• 11.2 RELATED REPORTS